DeepTek
DeepTek is a Pune-based AI medical imaging company founded in 2017 that builds FDA-cleared and WHO-recommended deep learning solutions for radiology workflow optimization and tuberculosis screening, serving hospitals, imaging centers, government health programs, and NGOs across 21+ countries.
- Company typePrivate
- Founded2017
- HeadquartersPune, India
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What DeepTek does
DeepTek is a Pune, India-based medical imaging AI company founded in 2017 that develops AI-powered radiology workflow and diagnostic solutions for hospitals, imaging centers, government health programs, and NGOs. Its core technology uses deep learning architectures (CNN, FPN, U-Net, ResNet, VGG, GoogLeNet) to analyze chest X-rays, CT scans, and MRI images, augmented by a differentiated expert-in-the-loop feedback system that incorporates radiologist audits to continuously improve model accuracy. The company addresses the global radiologist shortage with measurable productivity gains (86% improvement) and 46% faster reporting times.
The product portfolio centers on Augmento Enterprise, a US FDA-cleared AI deployment platform combining Cloud PACS, advanced viewing, analytics, and multi-vendor AI management; Genki, an offline-capable AI-powered TB screening solution for population-level public health programs; the FDA-cleared CXR Analyzer (CADe software); Augmento X-Ray reporting automation; and an AI-driven teleradiology service featuring Agentic AI-powered reporting. DeepTek holds US FDA 510(k) clearance, CE MDR Class IIb certification, WHO recommendation for TB screening, Thai FDA approval, and the IndiaAI-NCG CATCH Grant 2026.
Revenue is generated through three streams: subscription/recurring licensing of the Augmento Enterprise platform, recurring AI-powered teleradiology outsourcing services, and managed-services contracts for public health screening programs (primarily TB). The company sells primarily through direct enterprise field sales targeting hospital and imaging center chains, supplemented by government engagement for national screening programs and channel partners (Doctor Net Japan, PSP Japan, Diagnosol Africa, BJC Thailand, Shimadzu APAC) for international expansion, with platform integrations through Blackford and deepcOS. As of 2026, DeepTek serves over 1,800 hospitals and imaging centers in India across 21+ states and 1,200+ globally across 21+ countries, with screening of over 1 million people for TB.
DeepTek firmographics
Firmographics- Name
- DeepTek
- Legal name
- DeepTek Medical Imaging Private Limited
- Website
- https://deeptek.ai
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- DeepTek is a Pune-based AI medical imaging company founded in 2017 that builds FDA-cleared and WHO-recommended deep learning solutions for radiology workflow optimization and tuberculosis screening, serving hospitals, imaging centers, government health programs, and NGOs across 21+ countries.
- Ownership category
- akta.pro rank
DeepTek industry classification
Industry- Product category
- Medical Imaging AI Software
- NAICS
- Software Publishers (51321), Computer Systems Design and Related Services (54151), Software Publishers (5132)
- SIC
- Services-Computer Programming Services (7371)
- akta.pro primary industry
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD), Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD)
Keywords
Where DeepTek is headquartered
LocationHeadquarters
- HQ city
- Pune
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
DeepTek business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- AI-Powered Teleradiology Outsourcing Services: Provides AI-assisted radiology reporting services to hospitals and imaging centers, combining AI workflows with human radiologist expertise to improve diagnostic turnaround times
- AI Deployment Platform Licensing: Licenses the Augmento Enterprise platform (Cloud PACS + AI deployment) to healthcare providers for operationalizing clinical AI across workflows
- Public Health Screening Solutions: Provides Genki TB screening solutions to governments and NGOs for population-level disease screening programs
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
DeepTek product offering
Product offeringCore offering
DeepTek develops and sells AI-powered radiology and medical imaging software products for hospitals, imaging centers, governments, and NGOs. Its portfolio centers on the Augmento Enterprise platform (AI deployment platform with cloud PACS, advanced CT/MR/PET-CT viewer, analytics, and collaboration tools), Genki (offline-capable AI lung health screening for population-level TB detection), Augmento X-Ray (chest X-ray reporting automation), the CXR Analyzer (FDA-cleared CADe software), and AI-driven teleradiology reporting services that combine automated AI workflows with human radiologist oversight.
Product overview
DeepTek is a radiology AI company offering a portfolio of FDA-cleared and CE-certified products centered around its Augmento Enterprise platform. Augmento Enterprise serves as the core AI deployment platform with PACS capabilities, supporting advanced viewing (CT/MR/PET-CT), comprehensive analytics, and collaboration tools. Genki is the AI-powered public health screening solution for population-level TB detection, operating independently with offline capabilities for remote deployment. Augmento X-Ray provides chest X-ray reporting automation with structured clinical report generation. The CXR Analyzer is the US FDA-cleared CADe software for detecting chest X-ray abnormalities. DeepTek also offers AI-driven teleradiology services combining AI workflows with human expertise, including Agentic AI-powered reporting. The Responsible AI Framework underpins all solutions with transparency, explainability, and post-deployment surveillance capabilities. The company processes imaging across X-rays, CT, and MRI modalities, screening for 22+ pathologies including TB, COVID-19, pneumonia, nodules, and cardiomegaly.
Differentiator
Problem solved
Functional benefit
Brands
- Augmento: AI-powered radiology deployment platform for healthcare providers featuring cloud PACS, advanced viewer, comprehensive analytics, and seamless collaboration
- Genki
- Augmento X-Ray
- CXR Analyzer
- DxPE AI Screen
- DxNodule AI Screen
Products and services
- Augmento Enterprise AI-powered radiology workflow optimization platform that serves as an enterprise PACS and AI deployment platform with advanced viewer (CT/MR/PET-CT), comprehensive analytics, and seamless collaboration tools. US FDA cleared and CE certified; deployed at Tata Memorial Hospital and adopted as National AI platform by Synapxe in Singapore.
- Genki AI-powered lung health screening tool designed for population-level TB screening programs. End-to-end screening solution that evaluates chest X-rays in 20-30 seconds, operates offline without internet connectivity, and is deployed in mobile diagnostic units and remote settings. WHO recommended for TB screening; 1 million+ people screened globally.
- Augmento X-Ray Chest X-ray reporting automation tool with automated segregation of scans with suspicions and automated structured clinical report generation. Includes Responsible AI post-deployment surveillance capabilities to monitor model performance and detect drift.
- CXR Analyzer US FDA-cleared CADe (Computer-Aided Detection) software that analyzes chest X-rays to support radiologists in detecting potential abnormalities in lung, pleura, and cardiac regions with color-coded bounding boxes. Integrates with existing PACS systems without disrupting radiology workflows.
- AI-Driven Teleradiology Reporting Services AI-driven diagnostic reporting service combining AI-assisted workflows with human radiologist expertise to improve diagnostic turnaround times and scale radiology operations. Includes Agentic AI-powered reporting capabilities; serves US teleradiology customers and Indian hospital and imaging center clients including Aarthi Scans, Ruby Hall Clinic, Vijaya Diagnostic Centre, and Sancheti Hospital.
- Chest X-ray AI for Clinical Usage US FDA-cleared chest X-ray AI solution designed for clinical usage by radiologists, with color-coded bounding boxes for abnormalities in lung, pleura, and cardiac regions. Listed as DeepTek's CADe CXR AI Solution on the company website.
Quantifiable outcome
- Over 99% sensitivity and 97% AUROC in TB screening, exceeding WHO benchmarks
- +6 more outcomes
Companies that use DeepTek
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles4 records
DeepTek technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability9 records
Feature7 records
DeepTek partnerships and signals
Strategic signalPartnerships
21 partnerships are on record, tiered core and strategic.
- Stop TB PartnershipcoreDeepTek participated in Stop TB Partnership U.S. Private Sector Summit at World Bank Spring Meetings 2026, presenting scalable TB screening solutions for resource-constrained settings.
- deepccoreLaunched fully integrated AI operating environment combining Augmento and deepcOS platforms for healthcare providers, enabling deployment, management, and scaling of multi-vendor clinical AI through a single operational layer.
- BlackfordcoreCommercial partnership to integrate DeepTek's CXR Analyzer into Blackford's Enterprise AI platform of over 140 AI-driven healthcare solutions, expanding market reach for chest X-ray analysis.
- Microsoft AzurestrategicStrategic cloud infrastructure partnership for hosting DeepTek's AI platforms and data processing capabilities.
- NVIDIAstrategicTechnology partnership for GPU computing and AI model training infrastructure, leveraging NVIDIA's AI platform for deep learning model development.
- NTT DATA JapanstrategicStrategic equity alliance and technology partnership with Japanese market-focused IT services company, part of broader relationship with NTT DATA ecosystem.
- Doctor Net (Japan)corePartnership with Japan's leading teleradiology firm for distribution of DeepTek's AI solutions in Japanese market.
- PSP (Japan)corePartnership with Japan's leading PACS firm for integration and distribution of DeepTek's radiology AI solutions.
- Dell TechnologiesstrategicTechnology partnership for hardware infrastructure supporting DeepTek's AI deployment solutions.
- Nobori (Japan)strategicStrategic partnership with Nobori Japan for radiology AI integration in Japanese market.
- World Health PartnersstrategicPartnership for delivering AI-assisted healthcare services in underserved regions through WHP's network.
- AWSstrategicAmazon Web Services cloud infrastructure partnership for AI platform deployment.
- Google CloudstrategicGoogle Cloud infrastructure partnership for AI platform hosting and data processing.
- Edison (GE)strategicPartnership through GE's Edison startup program for healthcare AI development and market access.
- Stemz GlobalstrategicStrategic equity investment by Stemz Global, a diversified group with Healthcare, Agriculture, and Manufacturing businesses and largest visa medical services provider in Asia and Middle East.
- BJC Healthcare (Thailand)corePartnership for Augmento deployment in Thailand healthcare facilities.
- ShimadzustrategicStrategic partnership with Shimadzu Asia Pacific and Middle East and Africa for radiology AI distribution.
- Diagnosol AfricacorePartnership for Genki TB screening solution deployment in Kenya.
- WHOcoreWHO recommended DeepTek's chest X-ray AI solution for TB screening, validating the technology for global health applications.
- ICMRstrategicPartnership with Indian Council of Medical Research for AI-driven TB detection research and implementation.
- FINDstrategicPartnership with Foundation for Innovative New Diagnostics for TB screening programs and diagnostics development.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
DeepTek competitors and assessment
Company assessmentDirect peers
- Qure.ai: India-based radiology AI competitor with overlapping chest X-ray (qXR), CT (qCT) and TB screening products, WHO-listed CAD software, and similar public health and hospital customer segments. Closest direct competitor.
- Aidoc: Israel/US-based AI radiology platform offering triage and orchestration across CT, MRI and X-ray modalities for hospitals and imaging centers — overlapping AI deployment platform positioning with Augmento.
- Annalise.ai: Australia-based comprehensive radiology AI suite covering chest X-ray and CT abnormalities; competes head-to-head with DeepTek's multi-pathology CXR and CT analysis modules in enterprise imaging.
- Lunit: Korean AI company with FDA-cleared Lunit INSIGHT CXR and TB screening AI — directly comparable chest X-ray CAD product, similar public health and hospital deployment model.
- Viz.ai: US-based radiology AI platform specializing in workflow orchestration and triage for stroke and other emergent imaging — comparable AI-deployment-platform model targeting enterprise hospital customers.
- deepc: Munich-based AI operating system for radiology that integrates multi-vendor clinical AI — directly overlaps Augmento's AI orchestration layer and is now a DeepTek integration partner.
- Blackford Analysis: Edinburgh-based enterprise AI platform aggregating 140+ radiology AI solutions — directly comparable multi-vendor AI marketplace/distribution model; current DeepTek distribution partner via Blackford platform.
Broad incumbents
- Zebra Medical Vision (Nanox): Israel-origin radiology AI vendor (now under Nanox) with broad chest, CT and bone AI algorithms — competing broad radiology AI suite with deeper balance sheet via Nanox acquisition.
- Philips (HealthSuite Imaging / AI): Global imaging OEM with embedded AI in PACS, Advanced Visualization Workspace and Intellispace; competes indirectly through bundled enterprise imaging contracts where DeepTek must displace or co-exist.
- GE Healthcare: Global imaging equipment and Edison AI platform vendor offering embedded radiology AI and Edison Marketplace; incumbent partner (DeepTek in GE Edison program) and competitor for enterprise AI deployment budgets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
DeepTek social profiles
Digital presenceDeepTek compliance and trust
Trust signalCompliance5 records
DeepTek financial estimates
Financial estimateRevenue estimate
Valuation estimate
DeepTek leadership team
Management profileNumber of profiles
Profiles8 records
DeepTek funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DeepTek M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DeepTek
What does DeepTek do?
DeepTek develops and sells AI-powered radiology and medical imaging software products for hospitals, imaging centers, governments, and NGOs. Its portfolio centers on the Augmento Enterprise platform (AI deployment platform with cloud PACS, advanced CT/MR/PET-CT viewer, analytics, and collaboration tools), Genki (offline-capable AI lung health screening for population-level TB detection), Augmento X-Ray (chest X-ray reporting automation), the CXR Analyzer (FDA-cleared CADe software), and AI-driven teleradiology reporting services that combine automated AI workflows with human radiologist oversight.
Is DeepTek a public or private company?
DeepTek is a private company. It is classified as venture growth investor backed and is currently operating.
When was DeepTek founded?
DeepTek was founded in 2017. It employs 101 to 250 people.
Where is DeepTek based?
DeepTek is headquartered in Pune, India, in the Asia region.
How does DeepTek make money?
Three revenue lines are on record. AI-Powered Teleradiology Outsourcing Services are the primary driver. The others are AI Deployment Platform Licensing and public Health Screening Solutions.
Who are DeepTek's main competitors?
Direct peers on record are Qure.ai, Aidoc, Annalise.ai, Lunit, Viz.ai, deepc and Blackford Analysis. Broad incumbents are Zebra Medical Vision (Nanox), Philips (HealthSuite Imaging / AI) and GE Healthcare.
Does DeepTek have an API?
No public API is recorded for DeepTek.
What industry is DeepTek in?
DeepTek's product category is Medical Imaging AI Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 51321 and its SIC code is 7371.